Skip to main content
Log in

Quantitative Relationship Between Solubility, Initial Dissolution Rate and Heat of Solution of Chiral Drugs

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of this study was to clarify the quantitativerelationship between solubility, initial dissolution rate and heat of solution ofracemic compound and its enantiomers.

Methods. Propranolol, propranolol HCl, tyrosine, and tryptophan wereused as typical chiral drugs. The heat of solution of chiral drug wasmeasured by an isothermal microcalorimeter and the heat of fusionwas measured by a DSC. The free energy difference for the dissolutionof drug was calculated from the solubility and initial dissolution ratedata.

Results. The free energy difference and enthalpy difference of thedissolution between the racemic compound and enantiomer ofpropranolol, propranolol hydrochloride, tyrosine, and tryptophan were obtainedby the solubility, initial dissolution rate and heat of solution data. Agood linearity was observed in the free energy difference and theenthalpy difference for the dissolution of them, except for propranololHCl data. By considering the dissociation in solution, the data ofpropranolol HCl followed the regression line.

Conclusions. The free energy difference of the dissolution was linearlydependent on the enthalpy difference for the racemic compound andits enantiomers. The results fit the theoretical equation. It could bepossible to estimate the solubility of chiral insoluble drug from thethermal data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. S. P. Duddu and D. J. Grant. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state. Pharm. Res. 9:1083–1091 (1992).

    Google Scholar 

  2. L. Wearly, B. Antonacci, A. Cacciapuoti, S. Assenza, I. Chaudry, C. Eckhart, N. Levine, D. Loebenberg, C. Norris, R. Parmegiani, J. Sequeira, and T. Y.-Tomaine. Relationship among physicochemical properties, skin permeability, and topical activity of the racemic compoound and pure enatiomers of a new antifungal. Pharm. Res. 10:136–140 (1992).

    Google Scholar 

  3. H. Takahashi, R. Tamura, T. Ushio, Y. Nakajima, and K. Hirotsu. Ideal enantiometric resolution (preferential enrichment) by recrystallization of a racemic compound V: relationship between preferential enrichment and crystal structures. Chirality 10:705–710 (1998).

    Google Scholar 

  4. R. Tamura, H. Takahashi, T. Ushio, Y. Nakajima, K. Hirotsu, and F. Toda. Ideal enantiometric resolution (preferential enrichment) by recrystallization of a racemic compound. Part 6: Hydrogen bonding mode in the crystal structure. Enantiomer 3:149–157 (1998).

    Google Scholar 

  5. H. Takahashi, R. Tamura, T. Ushio, T. Nakai, K. Hirotsu, and F. Toda. Preferential enrichment: mode of polymorphic transformation of a mixed crystal into a racemic compound crystal. Mol. Cryst. Liq. Cryst. Sci. Technol., Sect. A 313:211–216 (1998).

    Google Scholar 

  6. R. Tamura, H. Takahashi, K. Hirotsu, Y. Nakajima, T. Ushio, and F. Toda. Unusual disordered crystal structure of a racemate exhibiting a novel enantimeric resolution: preferential enrichment. Angew. Chem., Int. Ed. 37:2876–2878 (1998).

    Google Scholar 

  7. M. Elsabee and R. J. Prankerd. Solid-state properties of drugs. III. Differential scanning calorimetry of chiral drug mixtures existing as racemic solid solutions, racemic mixtures or racemic compounds. Int. J. Pharm. 86:221–230 (1992).

    Google Scholar 

  8. S. Takagi and R. Fujishiro. Heats of mixing of optical isomers in solution: Calorimetric evidence of stereospecific effect. Chem. Commun. 480 (1968).

  9. M. Pudipeddi, T. D. Sokoloski, S. P. Duddu, and J. T. Carstensen. Calorimetric determination of the heat of precipitation of pseudoephedrine racemic compound · Its agreement with the heat of solution. J. Pharm. Sci. 84:1236–1239 (1995).

    Google Scholar 

  10. E. Fukuoka, M. Makita, S. Yamamura, and Y. Yoshihashi. Use of microcalorimetry in the field of pharmaceutical sciences. I. Measurement of drug dissolution from solid dosage forms. Chem. Pharm. Bull. 42:2139–2142 (1994).

    Google Scholar 

  11. S. Prakongpan, W. I. Higuchi, K. H. Kwan, and A. M. Molokhia. Dissolution rate studies of cholesterol monohydrate in bile acid · lecithin solution using the rotating-disk method. J. Pharm. Sci. 65:685–689 (1976).

    Google Scholar 

  12. H. Nogami, T. Nagai, and A. Suzuki. Studies on powdered preparations. XVII. Dissolution rate of sulfonamides by rotating disk method. Chem. Pharm. Bull. 14:329–338 (1966).

    Google Scholar 

  13. D. Q. M. Craig and J. M. Newton, Characterisation of polyethylene glycols using solution microcalorimetry. Int. J. Pharm. 74:43–48 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yonemochi, E., Yoshihashi, Y. & Terada, K. Quantitative Relationship Between Solubility, Initial Dissolution Rate and Heat of Solution of Chiral Drugs. Pharm Res 17, 90–93 (2000). https://doi.org/10.1023/A:1007578811049

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007578811049

Navigation